GENERAL CATALYST GROUP MANAGEMENT LLC
Q3 2026 Form 13-F

CAMBRIDGE, MASSACHUSETTS
CIK 0001637946 · CRD 162548 · SEC-registered investment adviser
$478.2M Reported Value Total

GENERAL CATALYST reports 49 total accounts under management (AUM). There are 49 discretionary accounts valued at $45,502,659,880, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
61 funds · $50.1B gross asset value
Venture Capital Fund: $47.3B · Other: $2.9B
Source: Form ADV filed 2026-10-05
Reported value
$478.2M
Quarter over quarter
-0.9%
Holdings
13
Top-10 concentration
99.8%

Filing Structure

Reports holdings for

Holdings reported by

Key People

Form ADV owners & control persons
Kenneth Irvine Chenault
MEMBER
Hemant Nmn Taneja
MEMBER
Mark Joseph Allen
HEAD OF FUND OPERATIONS

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2026 13F record

Q3 2026 13F filing summary

Q3 2026 Form 13F portfolio summary
Period of report September 30, 2026
Filed November 16, 2026
Form 13F-HR
Reported value $478.2M
Positions 13
Change in reported value +153.7%
New positions 3
Exited positions 4
Position turnover 41.2%
Top-10 concentration 99.8%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 16, 2026
13 $478.2M
Q2 2026 13F
Filed Aug 14, 2026
14 $188.5M
Q1 2026 13F
Filed May 15, 2026
12 $183.6M
Q4 2025 13F
Filed Feb 17, 2026
7 $221.7M
Q3 2025 13F
Filed Nov 14, 2025
8 $3.0B
Q2 2025 13F
Filed Aug 14, 2025
10 $4.3B
Q1 2025 13F
Filed Apr 16, 2025
11 $887.5M
Q4 2024 13F
Filed Jan 23, 2025
11 $1.1B
Q3 2024 13F
Filed Nov 6, 2024
11 $1.4B
Q2 2024 13F
Filed Aug 14, 2024
11 $1.2B
Q1 2024 13F
Filed May 10, 2024
11 $1.3B
Q4 2023 13F
Filed Feb 9, 2024
10 $1.3B
Q3 2023 13F
Filed Nov 9, 2023
11 $1.1B
Q2 2023 13F
Filed Aug 8, 2023
10 $1.2B
Q1 2023 13F
Filed Apr 14, 2023
10 $965.0M
Q4 2022 13F
Filed Feb 15, 2023
11 $889.0M
Q3 2022 13F
Filed Nov 9, 2022
15 $1.1B
Q2 2022 13F
Filed Jul 29, 2022
15 $1.1B
Q1 2022 13F
Filed May 5, 2022
15 $1.8B
Q4 2021 13F
Filed Feb 14, 2022
13 $2.6B

8 earlier quarters on file — choose one from the quarter menu above.

Top 13 holdings · Q3 2026

Largest Q3 2026 13F positions by reported value
# Holding Reported value % of portfolio
1 QCOM QUALCOMM INC $291.4M 60.94%
2 PBLS PARABILIS MEDICINES INC $51.7M 10.81%
3 AVBP ARRIVENT BIOPHARMA INC $45.3M 9.46%
4 CART MAPLEBEAR INC $30.6M 6.41%
5 MAZE MAZE THERAPEUTICS INC $28.2M 5.89%
6 ODTX ODYSSEY THERAPEUTICS INC $18.0M 3.76%
7 OSCR OSCAR HEALTH INC $9.2M 1.93%
8 CPNG COUPANG INC $1.1M 0.23%
9 META META PLATFORMS INC $957.2K 0.2%
10 AMZN AMAZON COM INC $880.0K 0.18%
11 CVNA CARVANA CO $548.2K 0.11%
12 DASH DOORDASH INC $238.6K 0.05%
13 MLM MARTIN MARIETTA MATLS INC $84.0K 0.02%

Values as reported on the Q3 2026 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings